Search results
Results from the WOW.Com Content Network
Blood Cancer Discovery is a peer-reviewed journal that publishes high-impact studies on all types of blood cancers. The current issue features articles on KLHL6, axicabtagene ciloleucel, SF3B1, and CHK1 inhibition in leukemia and lymphoma.
Cancer Discovery is a journal of the American Association for Cancer Research (AACR) that publishes high-impact cancer research. According to Clarivate, its 2024 impact factor is 30.6, ranking it among the top journals in the field.
Blood Cancer Discovery is a bimonthly journal that publishes advances in basic, translational, and clinical research of leukemia, lymphoma, myeloma, and associated diseases. The journal covers topics such as molecular and cellular features, therapy response and relapse, biomarkers, and personalized medicine.
The American Association for Cancer Research (AACR) publishes several journals covering various aspects of cancer research and medicine. Find out the scope, impact factor, editorial board, and submission system of each journal and select the most appropriate one for your manuscript.
Cancer Discovery publishes high-impact articles on cancer research and medicine with an impact factor of 30.6. The journal covers topics from laboratory to clinic to epidemiology and features news, research watch, and trending articles.
Blood Cancer Discovery; Cancer Discovery; Cancer Epidemiology, Biomarkers & Prevention; Cancer Immunology Research; Cancer Prevention Research; Cancer Research; Cancer Research Communications; Clinical Cancer Research; Molecular Cancer Research; Molecular Cancer Therapeutics
In this setting, their performance is likely suboptimal due to patients’ weakened immune systems, higher disease burden, and selection of multi-therapy resistance. There is hope that moving CAR T-cell treatment to a frontline setting may open a safer and more effective avenue of treatment.
In recognition of Blood Cancer Discovery's first Impact Factor of 11.4, the Journal presents this ARTicle showcase.
In recognition of Blood Cancer Discovery's first Impact Factor of 11.4, the Journal presents this ARTicle showcase.
Cancer Discovery is a peer-reviewed journal that publishes high-impact articles on cancer research and medicine. It has a print ISSN of 2159-8274 and an online ISSN of 2159-8290, but no impact factor is provided on the web page.